Business Segments Roche Holding AG

Equities

Market Closed - Swiss Exchange Other stock markets 16:30:08 23/06/2025 BST			5-day change	1st Jan Change
260.50 ^CHF	+0.46%		-0.91%	+1.96%

08:00am	Roche: positive Phase I/II data in hemophilia A	CF
06:33am	Roche's Hemophilia Drug Shows Hemostatic Normalization Potential in Early-stage Study	MT

See more © MarketScreener.com

See more © MarketScreener.com

Breakdown by Business Segment (CHF)

Fiscal Period: December	2020	2021	2022	2023	2024
Pharmaceutical Products
Pharmaceuticals - Roche Pharmaceuticals	44.33B	45.71B	46.35B	44.43B	46.34B
Total Assets	42.39B	44.86B	43.04B	46.08B	45.52B
CAPEX	-4.74B	-2.79B	-2.3B	-3.12B	-1.31B
D&A	2.88B	2.66B	2.14B	1.82B	1.72B
Operating Income	14.76B	12.6B	11.32B	13.87B	18.69B
Pharmaceuticals - Chugai	6.94B	8.36B	9.27B	7.2B	6.88B
Total Assets	6.92B	7.89B	8.89B	6.59B	6.38B
CAPEX	-745M	-727M	-532M	-490M	-307M
D&A	260M	249M	221M	196M	177M
Operating Income	2.65B	3.52B	3.99B	2.92B	3.28B
EBITDA	20.94B	19.89B	20.7B	21.43B	23.36B
Medical Testing, Analyzing, and Diagnostic Equipment
Diagnostics	13.87B	17.86B	17.82B	14.16B	14.46B
Total Assets	18.75B	21.46B	21.59B	20.48B	22.55B
CAPEX	-1.7B	-1.78B	-1.76B	-1.98B	-1.81B
EBITDA	3.77B	5.31B	4.8B	3.88B	3.7B
D&A	1.35B	1.46B	1.42B	1.37B	1.45B
Operating Income	2B	3.32B	3.32B	2.17B	2.4B
Corporate	-	-	-	-	-
Total Assets	381M	420M	445M	555M	631M
CAPEX	-57M	-103M	-92M	-88M	-69M
EBITDA	-435M	-506M	-486M	-3.34B	-3.52B
D&A	70M	70M	69M	77M	72M
Operating Income	-610M	-694M	-662M	-3.91B	-3.59B
Elimination	-4.8B	-6.08B	-7.02B	-5.35B	-5.29B
Total Assets	-2.95B	-4.08B	-4.63B	-3.03B	-2.98B
Operating Income	-267M	-596M	-497M	349M	38M
Total Assets	-	-	-	-	-
Total Assets	5.73B	6.85B	4.99B	5.38B	6.98B
Total Assets	6.61B	6.18B	4.78B	5.13B	10.34B

Geographical breakdown of sales (CHF)

Fiscal Period: December	2020	2021	2022	2023	2024
United States	28.63B	28.06B	29.31B	28.35B	30.17B
Total Assets	23.09B	25.54B	23.56B	26.41B	27.33B
CAPEX	-987M	-925M	-881M	-1.28B	-1.1B
Rest of Europe	9.78B	11.38B	10.33B	9.7B	10.29B
Total Assets	2.13B	2.07B	1.85B	1.67B	2.01B
CAPEX	-345M	-344M	-278M	-309M	-319M
Rest of Asia	8.63B	9.76B	9.85B	8.89B	9.08B
Total Assets	1.65B	1.66B	1.53B	1.41B	1.48B
CAPEX	-291M	-293M	-299M	-323M	-312M
Japan	4.25B	5.07B	6.45B	4.46B	3.29B
Total Assets	2.87B	3.06B	2.93B	2.7B	2.72B
CAPEX	-668M	-609M	-456M	-448M	-315M
Latin America	2.39B	2.75B	2.87B	2.97B	3.25B
Total Assets	310M	333M	368M	418M	457M
CAPEX	-106M	-116M	-138M	-192M	-176M
Germany	3.35B	4.32B	3.32B	2.89B	2.94B
Total Assets	4.97B	5.36B	5.32B	5.26B	5.49B
CAPEX	-515M	-635M	-668M	-612M	-612M
Africa, Australia and Oceania	1.32B	1.48B	1.52B	1.21B	1.25B
Total Assets	127M	145M	138M	131M	151M
CAPEX	-25M	-45M	-40M	-44M	-56M
Switzerland	1.1B	2.12B	1.67B	1.12B	1.23B
Total Assets	9.28B	9.11B	8.98B	9.12B	9.08B
CAPEX	-754M	-857M	-639M	-561M	-600M
Rest of North America	883M	916M	1.1B	838M	889M
Total Assets	113M	58M	51M	41M	198M
CAPEX	-2M	-2M	-3M	-5M	-6M